By SHELTON BUMGARNER
Marmot’s Hole Guest Blogger
We knew South Korea was cute, but still.
Sphere: Related ContentSouth Korea has come a long way since 1997 and 1998, when growth plunged. Banks are healthier, foreign-currency debt has been reduced, the family-owned conglomerates that dominated the economy have been reined in and currency reserves are near $200 billion.
Besides, South Korea is, well, cool. Actors like Bae Yong Joon and singers like BoA are taking Asia by storm, creating a lucrative industry for cultural exports. The economic ripple effects of the Korean Wave continue to multiply and offer new growth opportunities.
5 Comments
The Korean market is hot ticket and will remain so for some time. Look at a possible increase of 30% of what it is now and realistically 1400 soon.
Pharmaceuticals: All are great.
LS Cable ? Long term growth
And quite a few others out there, yahoo!
korean pharmaceuticals-are you serious? i haven’t been looking deeply into many pharmaceuticals in korea, but the foreign investors specialized in the industry that i know won’t touch ‘em here. what is your reason for thinking that they have decent, safe growth potential in korea?
Well put your money where your mouth is. I got a 100,000 won that says the pharmaceutical sector of the Korean stock market will outperform the Korean stock market as a whole in a 6 month period.
Your friends who ‘would not touch em?- too bad look at the market. This is the change that has happened in the last six months on some of the major players in Korean drug companies (prices in won).
ChoongwaePharm (001060)
21,850 to 39,500
Yuhan (000100)
88,800 to 137,000
DongaPharm (000640)
31,400 to 62,500
KDPharm (011040)
20,800 to 40,300
HanmiPharm (008930)
42,510 to 97,700
KeunwhaPharm (002250)
14,950 to 17,300
KwangdongPharm (009290)
2,605 to 3,590
Put or shut up. If you can?t afford 100,000 have your ??investor? friends back you up. If they are experts to say they would ?not touch Korean pharmaceuticals?? then they should see this an easy 100,000.
A blog is a pointless place to have an argument.
Put or shut up.
put what? i’m not interested in the short term plays.
pharmaceuticals are extremely competitive with huge development cycles and budgets. add to this FDA approval and korea’s track record getting drugs to market under FDA, and it just doesn’t make sense to put your money in for long-term, secure, stable growth. perhaps you’re correct with short-term gains.
your logic for growth is hindsight. it’s always 20-20 when looking at sectors after they’ve grown. given the already volatile nature of the korean stock market, it’s not pragmatic for me. good luck.
A blog is a pointless place to have an argument.
1.) i didn’t realize we were having an argument.
2.) this is probably one of the best places to have an argument.
I will take that as a timid no to 100,000 as a wager.blah blah blah….
Korea stocks rock